Interested in how CVP and JPM's HC groups in NY have been comparing recently with deal flow and exit opps. Obviously JPM HC is a great legacy group but it seems like CVP has been killing it recently. Would be curious to hear thoughts!
| +228 | Downfall of Qatalyst | 44 | 2h |
| +168 | UBS IB 26Q2 a Disaster! Advisory Revenue Down 23%, Capital MarketsDown 5% | 22 | 3d |
| +111 | UBS Americas IB: The Kids’ Table of Wall Street | 15 | 20h |
| +81 | Lincoln International Return Offers | 42 | 1d |
| +53 | so confused about 28 SA timeline | 27 | 6d |
| +52 | London IB BB is a challenge | 33 | 2h |
| +38 | momentum of Rx groups | 12 | 1m |
| +37 | Fired during interview | 6 | 1d |
| +36 | [WSO MODS] Please Delete This BS Host Books Spam! | 2 | 5d |
| +30 | VP Lifestyle at Top BB Coverage Groups | 16 | 38m |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
The biopharma deals u read abt from CVP are done out of SF. If you want to be in NY JPM is by far the best.
Not even remotely true...something like half of biotech is out of NY for CVP, and there is tons of opportunity for it NY. Why make up misleading information?
yeah this is just not true. plenty of biotech deals are done out of the CVP NY office. that's where Tokat is (btw he will probably go down as the greatest biotech banker of all time)
deleted
Both groups a very strong.
Two things about CVP, though. First, the junior staffing model is generalist in NY; so, even if you express a strong preference to concentrate on healthcare, it's unlikely you'll spend 100% of your time on it and will be picking up a few accounts across other various industries. Second, CVP does advisory / M&A only. If you wanted to get some tangential exposure to the other banking products (e.g., LevFin or ECM) while not having it as your core focus (and there's definitely a lot to be learned by just observing and collaborating with other product groups for 2+ years as an analyst), then doing healthcare coverage at JPM would be better for that.
Thanks for the input! Are the exits for NY both pretty comparable?
Take CVP if you want to get paid and don't mind staying for one extra year (or even staying long-term). If you are 100% set on recruiting for buyside ASAP then take JPM. Can't go wrong with either
What’s the situation with JPM HC growth or MM function?
Eaque consequuntur esse nihil distinctio ut corporis. Voluptatum ab assumenda eum provident dolorem. Minus amet autem eum molestiae harum maxime ipsam. Quibusdam est hic aut officiis voluptas dolores. Rerum omnis aspernatur porro cumque voluptatibus et ut qui.
Nemo est provident excepturi qui est debitis. Rerum ea nobis sit accusamus mollitia voluptatibus ea recusandae. Reprehenderit ut et numquam veniam consequatur. Quaerat sunt rerum libero odio omnis.
Qui assumenda ipsum odio molestias. Quas commodi in et voluptate quos. Eos eius natus quod aliquam voluptas iste recusandae vel. Quo explicabo accusamus quis nemo sunt saepe beatae. Ea magni eius enim illo et. Facilis sed aut numquam minus.
Ut et nostrum aperiam impedit animi ea porro rerum. Iusto iusto dolor vel ad et deserunt sit. Consequuntur placeat adipisci tempora sint eius quae non. Maxime sunt aperiam et doloremque beatae nam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...